Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer cells in vitro

Medical Science Monitor

Volumn 10, Issue 11, 2004, Pages

  Ławnicka, Hanna ^a   Potocka, Agnieszka M ^a   Juzala, Alina ^a   Fournie Zaluski, Marie Claude ^b   Pawlikowski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSERM   (France)

Author keywords

Angiotensins; Cell growth; Prostate cancer

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; EC 33; ENZYME INHIBITOR; LOSARTAN; PC 18; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROSTATE CANCER; PROTEIN FUNCTION; TUMOR CELL LINE; TUMOR GROWTH;

ANGIOTENSIN II; ANGIOTENSIN III; CELL LINE, TUMOR; CELL SURVIVAL; GLUTAMYL AMINOPEPTIDASE; HUMANS; MALE; PROSTATIC NEOPLASMS; SULFONIC ACIDS;

EID: 9144238230     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gill GN, Ill CR, Simonian MH: Angiotensin stimulation of bovine adrenal cell growth. Proc Natl Acad Sci USA, 1977; 74: 5569-73
2. Mc Ewen PE, Lindop GB, Kenyon CJ: Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system. Am J Physiol, 1996; 271: E192-E198
3. Paquet IL, Baudonin-Legros M, Brunelle I, Meyer P: Angiotensin II-induced cell proliferation of aortic myocytes in spontaneously hypertensive rats. Hypertension, 1990; 8: 565-72
4. Kunert-Radek J, Pawlikowski M: Angiotensin II stimulates the rat pituitary tumoral cells proliferation in vitro. Biochem Biophys Res Commun, 1992; 183: 27-30
5. Pawlikowski M, Kunert-Radek J: Angiotensin K stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun, 1997; 232: 292-93
6. Wang L, Eberhard M, Erne P: Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci, 1995; 88: 557-62
7. Pawlikowski M, Gruszka A, Mucha S, Melen-Mucha G: Angiotensin II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors. Endocr Reg, 2001; 35: 139-42
8. Pawlikowski M, Melen-Mucha G, Mucha S: The involvement of the renin-angiotensin in the regulation of cell proliferation in the rat endometrium. Cell Mol Life Sci, 1999; 55: 506-10
9. Dinh DT, Frauman AG, Sourial M et al: Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology, 2001; 142: 1349-56
10. Dinh DT, Frauman AG, Casley DJ et al: Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia. Mol Cell Endocrinol, 2001; 184: 187-92
11. Pawlikowski M, Melen-Mucha G, Mucha S: The involvement of angiotensins in the control of prostatic epithelial cell proliferation in the rat. Folia Histochem Cytobiol, 2001; 39: 341-43
12. Stone KR, Mickey DD, Wunderli H et al: Isolation of human prostate carcinoma cell line DU 145. Int J Cancer, 1978; 21: 274-81
13. Sompol P, Ding WJ, Shiro T et al: Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell cycle entry and apoptosis. Int J Cancer, 2002; 98: 167-72
14. Moretti RM, Momagnani Marell M, Motta M et al: Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells. The Prostate, 2001; 46: 327-35
15. Chauvel EN, Llorens-Cortes C, Coric P et al: Differentiation of aminopeptidase A and aminopepridase N by new b-aminothioles. J Med Chem, 1994; 65: 139-46
16. Fournie-Zaluski MC, Coric P, Turcaud S et al: Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J Med Chem, 1992; 35: 1259-68
17. Mosmann T: Rapid colorimetric method assay for cell growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth, 1983; 65: 55-63
18. de Gasparo M, Siragy HM: The AT2 receptor: fact, fancy and fantasy. Reg Peptides, 1999; 81: 11-24
19. Lehtonen JYA, Horiuch M, Daviett L et al: Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem, 1999; 274: 16901-6
20. Wolf G, Harendza S, Schroeder R et al: Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab Invest, 2002; 82: 1305-17
21. Cao Z, Kelly DJ, Cox A et al: Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney International, 2000; 58: 2437-51
22. Le MT, Vanderheyden PML, Szaszak M et al: Angiotensin IV is a potent agonist for constitutive active human ATI receptors. J Biol Chem, 2002: 277: 23107-10
23. Cook J, Zhang Z, Re RN: In vitro evidence for an intracellular site of angiotensin action. Circ Res, 2001; 90: 1138-46